Renee Lynch, OD
Optometrist · Portsmouth, NHNPI 1083066005
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,643 of the $5,190 with a category attached, or 89.4%. It is spread thinly across 23 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Among optometrist clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 160 payments — averaging $32.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$895
- Johnson & Johnson Surgical Vision, Inc.$745
- Alcon$547
- Bausch & Lomb Americas Inc.$494
- Sun Pharmaceutical Industries Inc.$431
- Dompe US, Inc.$287
- plus $2K from 17 others
What the payments were for
- Travel & lodging$54811%
- Food & beverage$4,64389%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 57 | $895 |
| Johnson & Johnson Surgical Vision, Inc. | 6 | $745 |
| Alcon | 14 | $547 |
| Bausch & Lomb Americas Inc. | 12 | $494 |
| Sun Pharmaceutical Industries Inc. | 16 | $431 |
| Dompe US, Inc. | 7 | $287 |
| Coopervision Inc. | 4 | $286 |
| Biotissue Holdings Inc. | 5 | $263 |
| LKC Technologies, Inc. | 1 | $201 |
| Sight Sciences, Inc. | 3 | $175 |
| Aerie Pharmaceuticals, Inc. | 8 | $140 |
| Novartis | 6 | $131 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $122 |
| Astellas Pharma US Inc | 1 | $103 |
| Johnson & Johnson Vision Care, Inc. | 1 | $56 |
| Thea Pharma Inc. | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Tarsus Pharmaceuticals, Inc. | 2 | $48 |
| Genentech USA, Inc. | 2 | $43 |
| Glaukos Corporation | 1 | $40 |
| Oyster Point Pharma, Inc. | 2 | $38 |
| Rayner Intraocular Lenses Limited | 1 | $28 |
| Omeros Corporation | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TearScience Lipiflow System$548
- TearScience Lipiview System$548
- TearScience Lipiscan System$548
- Rhopressa$146
- Rocklatan$146
- TearCare$142
- Prokera$121
- REVIVE$116
- TRYPTYR$111
- MIEBO$107
- Clariti Contact Lens$103
- Izervay$103
How this compares
$5,190 in reported general payments places this provider in the 95th percentile of 235 optometrist providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxervateCenegermin-Bkbj | 15 | $762,757 |
| RestasisCyclosporine | 104 | $138,858 |
| XiidraLifitegrast | 27 | $32,615 |
| Cyclosporine | 41 | $26,043 |
| MieboPerfluorohexyloctane/Pf | 11 | $8,116 |
| LumiganBimatoprost | 16 | $7,020 |
| CombiganBrimonidine Tartrate/Timolol | 17 | $4,844 |
| Loteprednol Etabonate | 21 | $2,600 |
| ValacyclovirValacyclovir Hcl | 20 | $2,127 |
| Prednisolone Acetate | 36 | $1,501 |
| Brimonidine Tartrate | 21 | $1,000 |
| Latanoprost | 92 | $554 |
| MoxifloxacinMoxifloxacin Hcl | 15 | $371 |
| Timolol Maleate | 30 | $193 |
| ErythromycinErythromycin Base | 16 | $94 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Dompe US, Inc.Oxervate | $287 | $762,75715 claims |
| AbbVieRestasis, Lumigan, Combigan | $895 | $150,722137 claims |
| Bausch & Lomb Americas Inc.Xiidra, Miebo | $494 | $40,73138 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $122 | $2,60021 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 235 optometrist providers in New Hampshire.
Other optometrist in Portsmouth
- Lauren McLoughlinPortsmouth$138K
- Sarah HudsonPortsmouth$6K
- Rinita TrahanPortsmouth$5K
- Jill FedericoPortsmouth$5K
- Puneet HarisinghaniPortsmouth$4K
- Nadiya OleksivPortsmouth$3K
- Christopher TurnerPortsmouth$2K
- Marcy SchultenoverPortsmouth$2K
- Nikolas MoorePortsmouth$2K
- Janet RandPortsmouth$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.